Abstract
Though the lateral frontal cortex is broadly implicated in cognitive control, functional MRI (fMRI) studies suggest fine-grained distinctions within this region. To examine this question electrophysiologically, we placed electrodes on the lateral frontal cortex in patients undergoing awake craniotomy for tumor resection. Patients performed verbal tasks with a manipulation of attentional switching, a canonical control demand. Power in the high gamma range (70-250 Hz) distinguished electrodes based on their location within a high-resolution fMRI network parcellation of the frontal lobe. Electrodes within the canonical fronto-parietal control network showed increased power in the switching condition, a result absent in electrodes within default mode, language, cingulo-opercular and somato-motor networks. High gamma results contrasted with spatially distributed power decreases in the beta range (12-30 Hz). These results confirm the importance of fine-scale functional distinctions within the human frontal lobe, and pave the way for increased precision of functional mapping in tumor surgeries.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Royal Society provided financial support in the form of a Royal Society Dorothy Hodgkin Research Fellowship to YE (DH130100). Cambridge Commonwealth European and International Trust provided financial support in the form of a Yousef Jameel scholarship to MA. Guarantors of Brain provided financial support in the form of a Post-Doctoral Fellowship award to RRG. The National Institute for Health Research (NIHR, UK) provided financial support in the form of a Clinician Scientist Award 35 to SJP (ref: NIHR/CS/009/011). The Brain Tumour Charity provided financial support in the form of a grant award to MGH (ref: RG86218). J.D was funded by a Medical Research Council grant (MC_UU_00005/6). This work was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) and NIHR Applied Research Centre.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
East of England - Cambridge Central Research Ethics Committee (REC reference 16/EE/0151)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This main edits to this revised version are repeating the statistics using linear mixed effects models (to account for subjects as a random variable). The re-analysis has replicated all the findings, thus suggesting the effects we observe are also present at the single subject level. We also added a power spectral density to figure 3 to show the raw power changes between conditions.
Data Availability
Due to clinical ethical considerations and in accordance with the ethics approval for the study by the East of England - Cambridge Central Research Ethics Committee (REC reference 16/EE/0151), the data cannot be shared or become publicly available.
